Stryker Corp
NYSE:SYK

Watchlist Manager
Stryker Corp Logo
Stryker Corp
NYSE:SYK
Watchlist
Price: 384.85 USD -1.36% Market Closed
Market Cap: 146.7B USD
Have any thoughts about
Stryker Corp?
Write Note

Stryker Corp
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Stryker Corp
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Stryker Corp
NYSE:SYK
Current Portion of Long-Term Debt
$2.2B
CAGR 3-Years
361%
CAGR 5-Years
33%
CAGR 10-Years
11%
Becton Dickinson and Co
NYSE:BDX
Current Portion of Long-Term Debt
$2.2B
CAGR 3-Years
63%
CAGR 5-Years
11%
CAGR 10-Years
27%
Boston Scientific Corp
NYSE:BSX
Current Portion of Long-Term Debt
$1.7B
CAGR 3-Years
85%
CAGR 5-Years
5%
CAGR 10-Years
88%
Edwards Lifesciences Corp
NYSE:EW
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
Current Portion of Long-Term Debt
$1.6B
CAGR 3-Years
29%
CAGR 5-Years
5%
CAGR 10-Years
23%
Intuitive Surgical Inc
NASDAQ:ISRG
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Stryker Corp
Glance View

Market Cap
146.7B USD
Industry
Health Care

Stryker Corporation, a prominent player in the global medical technology landscape, has carved out a reputation for innovation and reliability since its founding in 1941. Specializing in developing and manufacturing a diverse range of products, Stryker's offerings span surgical equipment, implantable devices, and medical instruments, all designed to enhance patient care and improve clinical outcomes. Fueled by a commitment to quality and continuous improvement, the company invests heavily in research and development, leading the way with cutting-edge technologies like robotic surgical systems and advanced orthopedic solutions. The company’s strong market position is bolstered by its strategic acquisitions, which not only expand its product portfolio but also deepen its penetration into key medical segments, allowing Stryker to sustain impressive growth rates. For investors, Stryker represents a compelling opportunity in the healthcare sector, driven by the increasing demand for advanced medical solutions in an aging global population. With a presence in over 100 countries, Stryker's diversified revenue streams reduce risk and enhance resilience against market fluctuations. The company consistently delivers solid financial performance, characterized by robust margins and healthy cash flows, which it strategically reinvests to fuel future growth. Furthermore, its strong commitment to sustainability and corporate responsibility positions Stryker favorably in a market increasingly concerned with ethical practices. As the healthcare industry continues to evolve, Stryker’s innovative edge and solid fundamentals make it a captivating prospect for investors seeking long-term stability and growth.

SYK Intrinsic Value
287.61 USD
Overvaluation 25%
Intrinsic Value
Price

See Also

What is Stryker Corp's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
2.2B USD

Based on the financial report for Sep 30, 2024, Stryker Corp's Current Portion of Long-Term Debt amounts to 2.2B USD.

What is Stryker Corp's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
11%

Over the last year, the Current Portion of Long-Term Debt growth was -6%. The average annual Current Portion of Long-Term Debt growth rates for Stryker Corp have been 361% over the past three years , 33% over the past five years , and 11% over the past ten years .

Back to Top